Skip to main content
Caplight Logo









Avant Genomics

Avant Genomics

Private
Charlottesville, VirginiaHealthcare & Life Scienceshttps://www.avant-genomics.com/

Last Round

Seed

May 13, 2026

Total Funding Raised

$3M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Avant Genomics is a biotechnology company developing a first-of-its-kind platform that automates liquid biopsy sample preparation for blood-based cancer detection.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Medical Devices, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Government Contracts

AI Layer

Non-AI

Keywords

liquid biopsy automationautomated sample preparationliquid biopsysample preparationsample prepcell-free DNAcfDNAlab automationprecision oncologylife sciences toolsdiagnostic equipmentbenchtop instrumentNGS sample preprazor and blades modelpicks and shovels play

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Avant Genomics Comparables

Compare Avant Genomics with similar companies based on industry and business-model similarity.

Avant Genomics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
nRichDX
85%
Apostle Inc.
74%
PerkinElmer
73%

Avant Genomics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 13, 2026

Key People

Founding team and executive leadership

Renna Nouwairi

Co-Founder & Chief Operating Officer

Founding Team

Rachelle Turiello

Chief Executive Officer

Executive Team

Daniel Goodall

CFO

Executive Team

Avant Genomics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 43% MoM.

  • May 13, 2026

    $3M round led by TitletownTech

Avant Genomics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Avant Genomics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Avant Genomics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCharlottesville, Virginia
Employee Range10
Year Founded2023
Last FundingMay 13, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?